Who might Grns not be a fit for, according to an RD
While GLP-1 RAs may cause some side effects, most commonly diarrhea, vomiting, and nausea, these range from mild to moderate and can be lessened by reducing the dose
Weight gain during this stage is driven by a significant decline in estrogen, which causes the body to redistribute fat specifically toward the abdomen and internal organs as visceral fat
in Singapore conducted a phase 1 study to assess the safety and the pharmacokinetic profile of retatrutide [35]
Patients should never share pens, should use a new needle for each injection, and should not store pens with needles attached
In my private practice, I started using GLP-1 drugs such as exenatide in 2006 and liraglutide in 2010 for my patients with type 2 diabetes